| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Adrian Haigh last filed a Form 4 in May 2024, as Chief Operating Officer at FENC. Adrian Haigh's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Adrian Haigh's trades have earned a strong insider score of 79/100 across 6 rated trades. Over a 12-month horizon, all 6 of those trades were profitable, with an average 12-month return of +46.7%.
Adrian Haigh has 11 Form 4 filings on record from June 2018 to May 2024, all as Chief Operating Officer at Fennec Pharmaceuticals (FENC), 2018–2024.
The 21 reported transactions were 10 open-market sales, 9 option or other derivative awards and 2 option exercises.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.5M.
The largest open-market sale was 88,888 shares of FENC at an average $6.30 on April 16, 2024, about $560K. Twelve months later FENC was down 50%.
All 3 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Operating Officer | Sale+OE10b5-1 | 44,445 | $9.33 | $414,471.84 | - | -30.0% | -42.0% | |
| Apr 18, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Operating Officer | Sale+OE10b5-1 | 88,888 | $6.04 | $536,661.30 | - | -30.5% | -46.9% | |
| Apr 16, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Operating Officer | Sale+OE10b5-1 | 88,888 | $6.30 | $559,847.73 | - | -36.3% | -50.3% |